Brief: Quest for Growth portfolio company Prosonix to be acquired by Circassia

Quest for Growth NV

15/05/2015 07:17

May 15 (Reuters) - Quest for Growth NV  QUFG.BR  
    * Expects a positive impact on its NAV of about 10 million 
euros ($11.37 million) or 0.86 euro per share because of 
Circassia Pharmaceuticals acquiring Prosonix 
    * Prosonix is the largest non-quoted investment in the Quest 
for Growth portfolio. 
 
     
     
Source text: http://bit.ly/1EJMbqd 
Further company coverage:  QUFG.BR  
 
 
($1 = 0.8794 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))